August 7, 2018
When each of us joined the Salk Institute, we signed on to a bold and collective mission far bigger and far more important than our work as individual scientists. Over the last year, the Institute’s collective nature has been put to the test, having entered into uncharted territory amidst very public litigation. As we have moved through the legal process, however, we have been reminded that, whatever our differences, we must never lose sight of our aspiration to work for the betterment of humanity and for each other. With that spirit in mind, in recent weeks the Institute’s leadership and Drs. Kathy Jones and Vicki Lundblad commenced discussions in hopes of resolving our disputes. Those productive conversations have led to a resolution of all claims between these parties that will enable us to put our disagreements behind us and move forward together at Salk for the collective good of the Institute and science.
Büro für Kommunikation
Telefon: (858) 453-4100
press@salk.edu
Das Salk Institute ist ein unabhängiges, gemeinnütziges Forschungsinstitut, das 1960 von Jonas Salk, dem Entwickler des ersten sicheren und wirksamen Polio-Impfstoffs, gegründet wurde. Die Aufgabe des Instituts besteht darin, grundlegende, kooperative und risikofreudige Forschung voranzutreiben, die sich mit den dringendsten Herausforderungen der Gesellschaft befasst, darunter Krebs, Alzheimer und die Gefährdung der Landwirtschaft. Diese Grundlagenforschung bildet die Basis für alle translationalen Bemühungen und führt zu Erkenntnissen, die neue Medikamente und Innovationen weltweit ermöglichen.
